This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Home » Keywords: » Drug Enforcement Administration (DEA)
Items Tagged with 'Drug Enforcement Administration (DEA)'
U.S. President Joe Biden briefly mentioned marijuana reform during last week’s State of the Union address, lifting industry hopes that cannabis rescheduling is on the horizon.
If cannabis is reclassified to Schedule III, cannabis businesses won't be encumbered by onerous operating and taxing obstacles, federally-funded cannabis research will finally occur, and investment will soar, writes Steve Schain.
While the industry awaits further guidance, Tyler Williams, founder and chief technical officer, Cannabis Safety & Quality, and Harvey Craig, founder and CEO of Harvey’s All Naturals, weighed in on what the DEA’s interim final rule could mean for both extractors and manufacturers of infused products.